Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Urdu Translation of Duke Activity Status

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04739163
Recruitment Status : Completed
First Posted : February 4, 2021
Last Update Posted : May 20, 2021
Sponsor:
Information provided by (Responsible Party):
Riphah International University

Brief Summary:
To translate, culturally adapt, and validate the Duke Activity Status Index (DASI) to the Pakistani Urdu language. The study will measure the reliability & validity of DASI in the Urdu version.No study has been conducted in the Pakistan region to translate DASI which follows the proper cross-culture adaptation.

Condition or disease
Heart Diseases

Detailed Description:

Literature suggested that Duke Activity Index (DASI) is a questionnaire originally developed in English To evaluate the functionality. DASI was used primarily to assess patients with cardiovascular diseases such as coronary artery disease, heart failure, myocardial ischemia, and infarction. In clinical practice, DASI can be used to know the effects of medical treatments and cardiac rehabilitation and to assist clinical decisions In controlled clinical trials, DASI can also be used to assess interventions and as a component for assessing the costs/benefits of treatment.

Studies demonstrated that DASI is characterized as a questionnaire with good functional ability, evidence of validity, usefulness, and great clinical and scientific applicability, it seems to be a useful tool for evaluating cardiac patients. So, to be used with Brazilian CVD patients it is necessary to validate DASI and verify its psychometric properties in this population.

Layout table for study information
Study Type : Observational
Actual Enrollment : 18 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Translation and Cross-cultural Adaptation of the Duke Activity Status Index to Urdu
Actual Study Start Date : October 1, 2020
Actual Primary Completion Date : March 1, 2021
Actual Study Completion Date : April 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Diseases




Primary Outcome Measures :
  1. Translation of Duke Activity Status Index (DASI) in Urdu [ Time Frame: 6 months ]
    The Duke Activity Status Index Scale (DASI) is a questionnaire, originally developed in English to assess the functional capacity. DASI has been used mainly to evaluate patients with cardiovascular diseases, such as coronary artery disease, heart failure, myocardial ischemia and infarction.


Secondary Outcome Measures :
  1. validity & reliability of Duke Activity Status Index Scale (DASI) in Urdu version [ Time Frame: 6 months ]
    Reliability and validity are concepts used to evaluate the quality of research. They indicate how well a method, technique or test measures something. Reliability is about the consistency of a measure, and validity is about the accuracy of a measure.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   22 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
To meet inclusion criteria participants will be diagnosed with heart disease, clinically stable, and able to read the Urdu version of DASI. Then patient response will be checked on the translated Urdu version.
Criteria

Inclusion Criteria:

  • Individuals have enough education level to understand Urdu and English as well with a body mass index between 18.6 and 39.9 kg/m with the diagnosis of cardiovascular diseases such as coronary artery disease, valvular heart disease, arrhythmia with at least one symptom11 such as chest pain, palpitations, fatigue, or dyspnea, and physician referral to exercise testing.

Exclusion Criteria:

  • Individual is unable to read the questionnaire, who have cognitive deficits screened by Mini-Mental State Examination according to the cut-off points and Hospitalization two months before as well as acute illness, fever, or severe physical limitation that would prevent from doing the exercise test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04739163


Locations
Layout table for location information
Pakistan
AllamaIqbal hospital
Sialkot, Punjab, Pakistan, 51040
Sponsors and Collaborators
Riphah International University
Investigators
Layout table for investigator information
Principal Investigator: Mehwish Waseem, MSPT(CPPT) Riphah International University
Publications:
Layout table for additonal information
Responsible Party: Riphah International University
ClinicalTrials.gov Identifier: NCT04739163    
Other Study ID Numbers: REC/00783 Abdul Majid Saeed
First Posted: February 4, 2021    Key Record Dates
Last Update Posted: May 20, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Riphah International University:
Duke activity status index
Heart Diseases
Tool Translation
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Diseases
Cardiovascular Diseases